Cargando…
Epigenetic and functional changes imposed by NUP98-HOXA9 in a genetically engineered model of chronic myeloid leukemia progression
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Fondazione Ferrata Storti
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927998/ https://www.ncbi.nlm.nih.gov/pubmed/32499242 http://dx.doi.org/10.3324/haematol.2020.249243 |
| _version_ | 1783659773064904704 |
|---|---|
| author | Sloma, Ivan Beer, Philip Desterke, Christophe Bulaeva, Elizabeth Bilenky, Misha Carles, Annaïck Moksa, Michelle Raghuram, Kamini Brimacombe, Cedric Lambie, Karen Turhan, Ali G. Wagner-Ballon, Orianne Gaulard, Philippe Humphries, Keith Hirst, Martin Eaves, Connie J. |
| author_facet | Sloma, Ivan Beer, Philip Desterke, Christophe Bulaeva, Elizabeth Bilenky, Misha Carles, Annaïck Moksa, Michelle Raghuram, Kamini Brimacombe, Cedric Lambie, Karen Turhan, Ali G. Wagner-Ballon, Orianne Gaulard, Philippe Humphries, Keith Hirst, Martin Eaves, Connie J. |
| author_sort | Sloma, Ivan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7927998 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Fondazione Ferrata Storti |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-79279982021-03-05 Epigenetic and functional changes imposed by NUP98-HOXA9 in a genetically engineered model of chronic myeloid leukemia progression Sloma, Ivan Beer, Philip Desterke, Christophe Bulaeva, Elizabeth Bilenky, Misha Carles, Annaïck Moksa, Michelle Raghuram, Kamini Brimacombe, Cedric Lambie, Karen Turhan, Ali G. Wagner-Ballon, Orianne Gaulard, Philippe Humphries, Keith Hirst, Martin Eaves, Connie J. Haematologica Letters to the Editor Fondazione Ferrata Storti 2020-06-04 /pmc/articles/PMC7927998/ /pubmed/32499242 http://dx.doi.org/10.3324/haematol.2020.249243 Text en Copyright© 2021 Ferrata Storti Foundation http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
| spellingShingle | Letters to the Editor Sloma, Ivan Beer, Philip Desterke, Christophe Bulaeva, Elizabeth Bilenky, Misha Carles, Annaïck Moksa, Michelle Raghuram, Kamini Brimacombe, Cedric Lambie, Karen Turhan, Ali G. Wagner-Ballon, Orianne Gaulard, Philippe Humphries, Keith Hirst, Martin Eaves, Connie J. Epigenetic and functional changes imposed by NUP98-HOXA9 in a genetically engineered model of chronic myeloid leukemia progression |
| title | Epigenetic and functional changes imposed by NUP98-HOXA9 in a genetically engineered model of chronic myeloid leukemia progression |
| title_full | Epigenetic and functional changes imposed by NUP98-HOXA9 in a genetically engineered model of chronic myeloid leukemia progression |
| title_fullStr | Epigenetic and functional changes imposed by NUP98-HOXA9 in a genetically engineered model of chronic myeloid leukemia progression |
| title_full_unstemmed | Epigenetic and functional changes imposed by NUP98-HOXA9 in a genetically engineered model of chronic myeloid leukemia progression |
| title_short | Epigenetic and functional changes imposed by NUP98-HOXA9 in a genetically engineered model of chronic myeloid leukemia progression |
| title_sort | epigenetic and functional changes imposed by nup98-hoxa9 in a genetically engineered model of chronic myeloid leukemia progression |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927998/ https://www.ncbi.nlm.nih.gov/pubmed/32499242 http://dx.doi.org/10.3324/haematol.2020.249243 |
| work_keys_str_mv | AT slomaivan epigeneticandfunctionalchangesimposedbynup98hoxa9inageneticallyengineeredmodelofchronicmyeloidleukemiaprogression AT beerphilip epigeneticandfunctionalchangesimposedbynup98hoxa9inageneticallyengineeredmodelofchronicmyeloidleukemiaprogression AT desterkechristophe epigeneticandfunctionalchangesimposedbynup98hoxa9inageneticallyengineeredmodelofchronicmyeloidleukemiaprogression AT bulaevaelizabeth epigeneticandfunctionalchangesimposedbynup98hoxa9inageneticallyengineeredmodelofchronicmyeloidleukemiaprogression AT bilenkymisha epigeneticandfunctionalchangesimposedbynup98hoxa9inageneticallyengineeredmodelofchronicmyeloidleukemiaprogression AT carlesannaick epigeneticandfunctionalchangesimposedbynup98hoxa9inageneticallyengineeredmodelofchronicmyeloidleukemiaprogression AT moksamichelle epigeneticandfunctionalchangesimposedbynup98hoxa9inageneticallyengineeredmodelofchronicmyeloidleukemiaprogression AT raghuramkamini epigeneticandfunctionalchangesimposedbynup98hoxa9inageneticallyengineeredmodelofchronicmyeloidleukemiaprogression AT brimacombecedric epigeneticandfunctionalchangesimposedbynup98hoxa9inageneticallyengineeredmodelofchronicmyeloidleukemiaprogression AT lambiekaren epigeneticandfunctionalchangesimposedbynup98hoxa9inageneticallyengineeredmodelofchronicmyeloidleukemiaprogression AT turhanalig epigeneticandfunctionalchangesimposedbynup98hoxa9inageneticallyengineeredmodelofchronicmyeloidleukemiaprogression AT wagnerballonorianne epigeneticandfunctionalchangesimposedbynup98hoxa9inageneticallyengineeredmodelofchronicmyeloidleukemiaprogression AT gaulardphilippe epigeneticandfunctionalchangesimposedbynup98hoxa9inageneticallyengineeredmodelofchronicmyeloidleukemiaprogression AT humphrieskeith epigeneticandfunctionalchangesimposedbynup98hoxa9inageneticallyengineeredmodelofchronicmyeloidleukemiaprogression AT hirstmartin epigeneticandfunctionalchangesimposedbynup98hoxa9inageneticallyengineeredmodelofchronicmyeloidleukemiaprogression AT eavesconniej epigeneticandfunctionalchangesimposedbynup98hoxa9inageneticallyengineeredmodelofchronicmyeloidleukemiaprogression |